Journal: Nature Communications
Article Title: Stem-like memory-T maintenance and differentiation into tissue-resident T cells sustain chronic graft-versus-host disease in mice
doi: 10.1038/s41467-026-69975-z
Figure Lengend Snippet: a Tsm, Trmp and Trm subsets were sorted from the liver and lung of cGVHD mice at day 30 after HCT and adoptively transferred into cGVHD recipients at day 14 after HCT. Adoptively transferred CD45.1 + CD4 + Tm subsets were analyzed 14 days later, as shown in the diagram. b Recovery of each injected Tm subset in the liver and lung 14 days after adoptive transfer, N = 4–8. c Percentages of Tsm, Trmp and Trm among cells derived from each injected Tm subsets are shown and calculated, N = 4–5. d %Tox positive T cells among injected CD45.1 + Tm subsets, N = 4 per group. e CD4 + Tm subsets were sorted from the liver and lung of primary cGVHD mice at day 30 after HCT and adoptively transferred into secondary cGVHD recipients established with Rag1 −/− -BM plus 0.1 M CD8 + T cells at day 15 after HCT, %baseline body weight and clinical GVHD score are shown, N = 8. f Representative Masion’ Trichrome panel (magnification, x100, N = 4) and pathology score are displayed. g Yields of Tsm, Trmp and Trm cells in the liver and lung derived from injected CD45.1 + Tm subsets, N = 5 or 6 per group. h %baseline bodyweight and %survival among cGVHD mice treated with anti-CD4 mAbs or control IgG weekly from day 29 to 50 after HCT. N = 7 or 10 per group. i Representative Masion’ Trichrome panel (magnification, x200) and pathology score on day 60 of IgG control and aCD4 mAbs group, ~day75 in the cGVHD recurrence group after HCT, N = 9, 4 or 5 per group. j Yields of Tm subsets in the liver and lungs of cGVHD recipients treated in ( h ). k %baseline bodyweight and %survival among cGVHD mice treated with aCD4 mAbs or control IgG weekly from day 29 to 99 after HCT. N = 13 or 14. Data presented as mean ± SEM from at least 2 replicates. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, as determined by one-way ANOVA ( b , d , f ), unpaired two-tailed t-test ( e , h , k ), log-rank test comparison of survival ( h , k ) and two-way ANOVA ( g , i , j ).
Article Snippet: cGVHD mice were treated with intraperitoneal (i.p.) anti-mouse CD4 mAbs (Bio X Cell, Clone GK1.5) weekly at 500 μg/mouse from day 29 to 50 after HCT or from day 29 to 99 after HCT.
Techniques: Injection, Adoptive Transfer Assay, Derivative Assay, Control, Two Tailed Test, Comparison